Head-to-head · Cost-Efficiency Index
Brello Health vs Shapely
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Brello Health
Shoppers comfortable with a mandatory 3-month auto-renewing commitment in exchange for a discounted per-month rate.
Visit Brello HealthShapely
Cost-first shoppers who want insured patients in CA, FL, NY, or TX who want help navigating coverage for branded GLP-1s.
Visit ShapelyThe verdict
Brello Health and Shapely tie on the Cost-Efficiency Index at 64/100, so neither wins outright on the numbers. For most shoppers we'd start with Brello Health (ranked #175, a hair above #182) — Shoppers comfortable with a mandatory 3-month auto-renewing commitment in exchange for a discounted per-month rate. But Shapely is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Brello Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Brello Health | Shapely |
|---|---|---|
| Cost-Efficiency Index | 64/100 | 64/100 |
| Semaglutide / mo | $133/mo (3-month plan, compounded) | $99/mo (plus a separate fee, compounded) |
| Tirzepatide / mo | $166/mo (3-month plan, compounded) | $166/mo (plus a separate fee, compounded) |
| Semaglutide / yr (modeled) | $1,596 | $1,188 |
| Tirzepatide / yr (modeled) | $1,992 | $1,992 |
| Coverage | 35 states | 4 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #175 | #182 |
Brello Health
64/100Where the value is
- Discount structure is itemized transparently — both the discounted and pre-discount standing price are shown side by side ($133 vs $198 for semaglutide, $166 vs $247 for tirzepatide)
- Bundle options combining GLP-1 with NAD+ and/or Sermorelin are available on the same subscription
- The commitment mechanics are explicitly disclosed on-site ('3-month minimum commitment and automatically renew every 11 weeks') rather than buried in terms of service
The tradeoffs
- No month-to-month option exists at any price — every plan requires a 3-month minimum and auto-renews every 11 weeks, a real commitment a shopper comparing 'per month' prices across sites could easily miss
- The compounding pharmacy is not named, only 'USA-based 503A Partner Pharmacy,' and the site discloses it is mid-transition to a new facility
Shapely
64/100Where the value is
- Named, credentialed founder (Dr. Justin Zaghi, Harvard-trained, board-certified obesity medicine)
- Genuine insurance-navigation service across 8 major payers, potentially large savings if covered
- Both cash-pay compounded and insurance-covered branded pathways offered
The tradeoffs
- Live in only 4 states (CA, FL, NY, TX) despite a '50-state expansion' announcement
- Separate membership fee stacks on top of medication cost, and its headline prices ($9 first month, $49/mo promo) are not the real ongoing rate ($99/mo)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.